Medicine Long Used for Respiratory Ills Seen to Help Parkinson’s Patients in Small Trial
A medicine approved in the late 1970s to clear the respiratory tract and thin mucus can also cross the blood-brain…
With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A medicine approved in the late 1970s to clear the respiratory tract and thin mucus can also cross the blood-brain…
A team of researchers at Purdue University won a $4 million grant from the National Science Foundation to…
A bioactive agent called baicalin prevented neurodegeneration of Parkinson’s disease in rats by protecting against oxidative stress and neuronal death,…
A Phase 1 clinical trial of MODAG Neuroscience Solutions’ lead candidate anle138b is now underway and recruiting healthy…
Aspen Neuroscience, a new biotech company, has raised $6.5 million to develop cell therapies for Parkinson’s disease using…
Second-hand smoke may have a neuroprotective effect, as exposure to this type of indoor pollutant seems to be associated…
An experimental model of Parkinson’s in non-human primates leads to the accumulation of iron — known to contribute to…
A small molecule that can protect the function of mitochondria — known as the powerhouses of cells — and prevent…
Tiny and traceable man-made crystals, known as quantum dots, may be useful in carrying toxins to select cells in the…
Cooper concentrations are significantly affected in the blood serum of Parkinson’s patients, suggesting this metal metabolism could somewhat influence…
Get regular updates to your inbox.